Article Details
Retrieved on: 2023-01-14 12:01:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Daiichi Sankyo announced its application for its mRNA vaccine's manufacture and sale on Friday, with plans to put it into use by the end of this year.
Article found on: mainichi.jp
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here